News
VRXA
0.9800
-2.00%
-0.0200
VERAXA Biotech (NASDAQ: VRXA) Expands Human-Relevant Testing Strategy to Advance Antibody-Based Cancer Pipeline
TipRanks · 5d ago
Weekly Report: what happened at VRXA last week (1012-1016)?
Weekly Report · 10/19 10:31
Veraxa Biotech presents in vivo, in vitro data for BiTAC-ADC technology platform
TipRanks · 10/13 11:15
Weekly Report: what happened at VRXA last week (1005-1009)?
Weekly Report · 10/12 10:37
VERAXA Biotech (NASDAQ: VRXA) Advances FDA-Aligned Methods to Reduce Animal Testing
TipRanks · 10/07 17:00
This Tiny Biotech Stock Is Down 96% This Year. Can Next-Gen Drug Testing Save It?
Barron‘s · 10/07 13:58
Micro-Cap Stock Veraxa Biotech Is Down 96% This Year. Can Next-Gen Drug Testing Save It?
Barron‘s · 10/07 13:09
Veraxa Biotech to implement FDA-aligned NAMs across development programs
TipRanks · 10/07 11:20
VERAXA Biotech Adopts FDA-Aligned Models To Support Oncology Development
NASDAQ · 10/07 11:11
Weekly Report: what happened at VRXA last week (0928-1002)?
Weekly Report · 10/05 10:36
Veraxa Biotech Director Makes Bold Move With Fresh Insider Buy
TipRanks · 09/30 02:01
Weekly Report: what happened at VRXA last week (0921-0925)?
Weekly Report · 09/28 10:31
VERAXA Biotech (NASDAQ: VRXA) Advances Oncology Pipeline as Xlife Sciences Reports First-Half Progress
TipRanks · 09/24 16:00
VERAXA Biotech (NASDAQ: VRXA) Builds Oncology Pipeline Around BiTAC Platform, Public-Market Story Enters Next Phase
TipRanks · 09/22 15:30
Weekly Report: what happened at VRXA last week (0914-0918)?
Weekly Report · 09/21 10:31
VERAXA Biotech (NASDAQ: VRXA) Adds Capital Markets Veteran as CFO While Advancing BiTAC Oncology Pipeline
TipRanks · 09/18 18:31
VERAXA Biotech (NASDAQ: VRXA) Building a New Approach to Precision Cancer Therapy
TipRanks · 09/16 16:30
Weekly Report: what happened at VRXA last week (0907-0911)?
Weekly Report · 09/14 10:37
VERAXA Biotech (NASDAQ: VRXA) Appoints Raju Willener as Chief Financial Officer
TipRanks · 09/08 16:00
Weekly Report: what happened at VRXA last week (0831-0904)?
Weekly Report · 09/07 10:29
More
Webull provides a variety of real-time VRXA stock news. You can receive the latest news about Veraxa Biotech AG through multiple platforms. This information may help you make smarter investment decisions.
About VRXA
Veraxa Biotech AG is a Switzerland-based Company that develops antibody-based therapeutics for the treatment of cancer. The Company focuses on advancing proprietary platform technologies designed to generate targeted oncology therapies with improved safety and efficacy profiles. Its approach originates from scientific discoveries at the European Molecular Biology Laboratory, supporting the development of next-generation antibody-based drug candidates. The Company aims to expand treatment options for solid tumors by enabling more precise targeting mechanisms and potentially broader therapeutic windows compared with conventional therapies, addressing unmet needs across oncology markets through platform-driven innovation.